HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 140 filers reported holding HERON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $353,421 | -10.3% | 343,127 | +1.1% | 0.00% | 0.0% |
Q2 2023 | $393,790 | -63.0% | 339,474 | -51.9% | 0.00% | -60.0% |
Q1 2023 | $1,065,572 | +154.2% | 705,677 | +320.9% | 0.01% | +150.0% |
Q4 2022 | $419,133 | -42.6% | 167,653 | -3.1% | 0.00% | -50.0% |
Q3 2022 | $730,000 | +182.9% | 173,053 | +985.7% | 0.00% | +300.0% |
Q1 2021 | $258,000 | -52.5% | 15,940 | -37.9% | 0.00% | -50.0% |
Q4 2020 | $543,000 | +42.5% | 25,650 | -0.2% | 0.00% | 0.0% |
Q3 2020 | $381,000 | +5.8% | 25,700 | +5.0% | 0.00% | 0.0% |
Q2 2020 | $360,000 | +102.2% | 24,470 | +61.1% | 0.00% | +100.0% |
Q1 2020 | $178,000 | -51.1% | 15,194 | +2.0% | 0.00% | -50.0% |
Q1 2019 | $364,000 | -28.8% | 14,890 | -24.4% | 0.00% | -33.3% |
Q4 2018 | $511,000 | +100.4% | 19,690 | +144.6% | 0.00% | +200.0% |
Q3 2018 | $255,000 | – | 8,050 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN C | 760 | $1,900 | 100.00% |
Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
CM Management, LLC | 250,000 | $625 | 0.75% |
Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |